Skip to main content

Table 3 Significant factors in multivariate analysis for outcome measures

From: Radical radiotherapy with concurrent weekly cisplatin in loco-regionally advanced squamous cell carcinoma of the head and neck: a single-institution experience

Prognostic factor p-value Hazard Ratio 95% Confidence Interval
Local Control    
   Stage grouping (III vs IV) 0.013 1.816 1.134 – 2.908
   Primary site (oral vs non-oral) 0.001 0.648 0.497 – 0.845
   No of CT cycles (less vs more) 0.038 0.643 0.424 – 0.977
Loco-regional Control    
   Stage grouping (III vs IV) 0.000 2.406 1.551 – 3.734
   No of CT cycles (less vs more) 0.014 0.627 0.432 – 0.909
Disease Free Survival    
   Stage grouping (III vs IV) 0.000 2.640 1.707 – 4.081
   No of CT cycles (less vs more) 0.016 0.642 0.447 – 0.922